Previous issue | Volume 98 | ESPE2024

62nd Annual ESPE (ESPE 2024)

Liverpool, UK
16 Nov 2024 - 18 Nov 2024

Card image cap
The 62nd ESPE Annual Meeting will now be taking place in Liverpool, UK.

Free Communications

Fat, Metabolism and Obesity 2

hrp0098fc11.1 | Fat, Metabolism and Obesity 2 | ESPE2024

Frequency of rare syndromic diseases in a population with early-onset obesity

Goldstone Anthony , Nazlı Gönç Elmas , Manco Melania , Rachmiel Marianna , Rivera Cuello Mercedes , Sleiman Patrick , Savoie Charles , Argente Jesús , le Roux Carel

Introduction: Patients with genetic variants in the melanocortin-4 receptor (MC4R) pathway may present with hyperphagia and early-onset obesity. Increasing awareness of genetic testing could improve diagnosis and identification of patients who might benefit from novel precision therapies. Moreover, the frequency of specific genetic variants in this population is currently unknown. The Rare Obesity Advanced Diagnosis ™ (ROAD) genetic testing prog...

hrp0098fc11.2 | Fat, Metabolism and Obesity 2 | ESPE2024

Frequency of rare non-syndromic diseases in a population with early-onset obesity

le Roux Carel , Rabbone Ivana , Haliloglu Belma , Pinhas-Hamiel Orit , Dominguez-Riscart Jesús , Sleiman Patrick , Savoie Charles , Goldstone Anthony , Argente Jesús

Introduction: Genetic variants in the melanocortin-4 receptor (MC4R) pathway can lead to hyperphagia and early-onset obesity. Increasing awareness of genetic testing may aid in the diagnosis and identification of patients who could benefit from novel precision therapies. To enhance access to genetic testing for patients with suspected rare MC4R pathway diseases, the Rare Obesity Advanced Diagnosis ™ (ROAD) genetic testing program was established...

hrp0098fc11.3 | Fat, Metabolism and Obesity 2 | ESPE2024

Asprosin serum levels in subjects with Prader-Willi Syndrome: associations with hyperphagia, anthropometric, and metabolic parameters

Felicia Faienza Maria , Chiarito Mariangela , Aureli Alessia , Buganza Raffaele , Corica Domenico , Delvecchio Maurizio , De Sanctis Luisa , Fintini Danilo , Grugni Graziano , Rosaria Licenziati Maria , Madeo Simona , Mozzillo Enza , Rutigliano Irene , Valerio Giuliana

Introduction: Asprosin is a new discovered adipokine involved in the regulation of appetite, glucose, and energy homeostasis. The aim of our study was to evaluate asprosin serum levels in children and adults affected with Prader-Willi Syndrome (PWS), and to compare with hyperphagia questionnaire (HFQ), anthropometric and metabolic parameters.Methods: This cross-sectional study included 118 PWS subjects (88 children, mean...

hrp0098fc11.4 | Fat, Metabolism and Obesity 2 | ESPE2024

Long-term Efficacy Results of Diazoxide Choline Extended-Release (DCCR) Tablets in Participants with Prader-Willi Syndrome from the Completed C601 (DESTINY PWS) and C602 Open Label Extension (OLE) Studies

Gevers Evelien , Bridges Nicola , Yanovski Jack , Felner Eric , Salehi Parisa , Hall Shoemaker Ashley , Fleischman Amy , Goldstone Anthony , Angulo Moris , Stevenson David , Obrynba Kathryn , Guftar Shaikh M , Holland Anthony , Mathew Verghese , Viskochil David , E. McCandless Shawn , Bird Lynne , Lah Melissa , Kimonis Virginia , Abuzzahab Jennifer , Konczal Laura , Littlejohn Elizabeth , Shea Heidi , Dharmaraj Poonam , Das Urmi , Mejia-Corletto Jorge , Wilding John , Harwood Katerina , Yen Kristen , Gandhi Raj , Gong Jing , Hirano Patricia , Cowen Neil , Bhatnagar Anish , Huang Michael , Butler Merlin , Miller Jennifer

Background: Prader-Willi syndrome (PWS) is a rare genetic neurobehavioral-metabolic disorder characterized by hyperphagia and behavioral/psychological complications. No approved therapies exist for treating hyperphagia in patients with PWS. DCCR is an oral, once-daily medication currently under development for the treatment of PWS.Objective: The objective was to determine the efficacy of investigational DCCR on hyperphag...

hrp0098fc11.5 | Fat, Metabolism and Obesity 2 | ESPE2024

Complement 3 Alleviates Obesity Hypoventilation by Inhibiting Caspase-8/GSDME-Related Pyroptosis

Sun Yan , Song Qijun , Han Linqi

Background and Purpose: Nutritional obesity is a significant health issue worldwide, and severe obesity can lead to obesity hypoventilation syndrome (OHS). However, previous studies have mainly focused on changes of mechanical respiratory function without in-depth study on damage of lung epithelial cells. This study investigates the molecular mechanism underlying obese hypoventilation.Methods: C57BL/6 mice were used to c...

hrp0098fc11.6 | Fat, Metabolism and Obesity 2 | ESPE2024

Poly- and Perfluoroalkyl substances (PFAS) levels and breastfeeding have opposite associations with growth and body composition at age 3 years

van Beijsterveldt Inge , Dorrepaal Demi , van Zelst Bertrand , van den Berg Sjoerd , Hokken-Koelega Anita

Background and aims: Poly- and perfluoroalkyl substances (PFAS) are non-degradable, man-made-chemicals. PFAS are considered to be ‘Endocrine Disrupting Chemicals’ (EDCs), a group of chemicals which have been reported to interfere with endocrine processes and cause adverse effects on perinatal, neurodevelopmental, metabolic and reproductive outcomes. Especially when exposure occurs during susceptible periods of human development, such as early life....